admin – Page 4181 – Get News Story

Referenda as a Meme: Non-doers community invites everyone to agree on something together

A Global Movement Invites Everyone to Participate in a Unique Non-Political Referendum

February 6, 2025 – The global doNONdo movement is launching an unprecedented event: the doNONdo Referenda. Unlike traditional referendums, this initiative has nothing to do with politics. Instead, it serves as the official community launch of doNONdo, a movement that embraces the transformative power of non-doing.

What is doNONdo?

doNONdo is a global community of non-doers—individuals who consciously practice Nothing for the benefit of all living beings. Rooted in mindfulness, mental well-being, and global harmony, doNONdo aligns with the growing trends of mental health awareness and sustainable living. The movement advocates that, in a world obsessed with action, intentional stillness can be the most powerful act of all.

What Does the Referenda Agreement Mean?

The core of the doNONdo Referenda is a simple yet profound agreement that anyone on this planet can fulfill:

By signing the Referenda Agreement, each participant affirms:

“I wholeheartedly acknowledge the significance of the practice of non-doing and commit to joining the doNONdo community for the benefit of all living beings.”

How to Participate in the doNONdo Referenda?

The process is simple and consists of two main steps:

1. The Practice of Non-Doing

– On February 24, 2025, at 12 PM (local time), participants will practice non-doing for at least 10 minutes. If you can practice for longer, it will bring even greater benefits to all living beings.

– This is a trust-based practice—you do not need to report or prove your participation to anyone. Just stop, be still, and embrace the power of Nothing.

2. The NFT Recognition

– On the same day, all blockchain addresses holding at least 10 dNd10 tokens will receive a special NFT—a unique digital record of the historical Referenda on the blockchain.

– No purchase is required. You can obtain dNd10 tokens for free by participating in the doNONdo Marathon.

These two simple steps complete the doNONdo Referenda and mark the official launch of the doNONdo community.

What Comes Next?

With the Referenda setting the foundation, doNONdo moves toward its next major initiative: “Releasing a State Without a State.” This creative and thought-provoking concept will further enrich the doNONdo vision, merging philosophy, technology, and playfulness to redefine what it means to coexist in stillness.

About doNONdo

doNONdo is a global initiative that promotes the practice of non-doing as a means to cultivate peace, reduce stress, and create harmony in an increasingly chaotic world. Founded by M1a0 Shan of Kata Dvaya, the movement spans over 100 countries and engages thousands of participants.

With its community token on the Solana blockchain and a philosophy deeply rooted in art and stillness, doNONdo transcends cultural and geographical boundaries, inviting everyone to experience the transformative power of doing Nothing.

For media inquiries, please contact:

SweetMoon@donondo.com

www.doNONdo.com

To view original press release, please visit https://prbuzz.co/news/1798218/referenda-as-a-meme-nondoers-community-invites-everyone-to-agree-on-something-together

Disclaimer: This press release may contain forward-looking statements. Forward-looking statements describe future expectations, plans, results, or strategies (including product offerings, regulatory plans and business plans) and may change without notice. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements.

Media Contact
Company Name: DoNONdo
Email: Send Email
Country: United States
Website: https://donondo.com/

Marine Toys for Tots “Not So Random Acts of Kindness” Initiative Provides Year-Round Support and Intentional Giving to Disadvantaged Children and Disaster-Stricken Families of the California Wildfires

As we step into a new year, our resolve has never been stronger. The Marine Toys for Tots Program remains committed to supporting those in need all year long, because we know that needs don’t follow a seasonal timetable.

While February is recognized as National Random Acts of Kindness month, at Marine Toys for Tots, they believe kindness knows no boundaries—nor does it follow a calendar. Kindness is intentional, and their year-round mission embodies this philosophy through their “Not So Random Acts of Kindness” initiative—a mission that enables the Program to deliver optimism and joy to children in need every day of the year and achieve record-breaking milestones.

Toys for Tots‘ donors’ intentional giving throughout 2024 enabled them to achieve a truly unprecedented, unmatched, and remarkable year. The Marine Corps Reserve Toys for Tots Program delivered over 30 million toys, books, and games to nearly 13 million children in need!

“I am deeply humbled by the incredible generosity of our supporters. Every donation and every act of kindness strengthens our mission and allows us to reach more disadvantaged children, year after year. Together, we are truly making a difference,” said LtGen Laster, USMC (Retired), CEO of the Marine Toys for Tots Foundation.

As they step into a new year, their resolve has never been stronger. The Marine Toys for Tots Program remains committed to supporting those in need all year long, because they know that needs don’t follow a seasonal timetable. Whether assistance is needed during the holiday season or following a crisis like Hurricane Helene or the California wildfires, Toys for Tots stands ready to help families and children who are facing unimaginable challenges and adversity.

In 2024, thanks to compassionate supporters, the Program met nature’s random brutality with a huge outpouring of kindness. Girls and boys who had lost their homes, their belongings, and their sense of security received a glimmer of hope at our emergency distribution event in Henderson County, North Carolina. In total, over 10,000 toys, books, and games made their way into the hands of 2,600 families.

Just like the support they gave to the families whose lives were turned upside down in North Carolina after Hurricane Helene, they will provide comfort and assistance to children and families in the communities surrounding Los Angeles.

“The tragic fires in Los Angeles have put countless families in crisis, disrupting their lives and destroying homes. While our hearts ache for those affected, our dedication to assisting those in need remains steadfast,” stated LtGen Laster.

“Los Angeles is where Toys for Tots began 78 years ago, and in response to the wildfires ravaging our Program’s birthplace, we are assembling and preparing to distribute emotional relief packages through our Disaster Response and Recovery Initiative to deliver toys, books, and other gifts that will provide comfort and a little bit of joy and hope to the children and families impacted by this disaster,” LtGen Laster added.

The gifts will be provided to our partners, Sidney Paige Foundation and Tackle Hunger, who will distribute to children and families in Los Angeles communities throughout early February. The toys, books and other gifts provided by Toys for Tots will offer vital comfort and care to children impacted by these disasters, providing them with hope and a sense of normalcy during their most challenging times. While natural disasters may be random, their supporters’ generosity is deliberate and intentional, enabling them to be an even stronger force for good in 2025.

For More Information, Please Visit:

Facebook/Meta

Instagram

Media Contact
Company Name: Marine Toys for Tots Foundation
Contact Person: Ted Silvester, Vice President of Marketing and Development
Email: Send Email
Phone: (703) 649-2021
City: Triangle
State: Virginia
Country: United States
Website: https://www.toysfortots.org/

Collaborative Home Care Enhances Senior Well-Being with 24-Hour Care in Stamford, CT.

Supporting families with compassionate, private 24-hour home care solutions tailored for Stamford’s senior community.

Stamford, CT – Collaborative Home Care, a trusted name in senior care, proudly announces its continued dedication to providing compassionate private 24-hour home care in Stamford, CT. This initiative underscores the company’s commitment to enhancing the quality of life for seniors and their families by offering personalized, around-the-clock care tailored to the unique needs of Stamford’s aging population.

“At Collaborative Home Care, we believe that every senior deserves to live with dignity and respect, no matter their health challenges,” said Bryan Knust, owner of Collaborative Home Care. “Our 24-hour home care services are designed to deliver the highest standard of compassionate care, ensuring peace of mind for families while promoting the independence and well-being of their loved ones.”

With the growing demand for private 24-hour home care in Stamford, CT, Collaborative Home Care emphasizes providing tailored solutions for seniors with chronic conditions, cognitive impairments, or disabilities. The care model integrates professional caregiving expertise with a compassionate approach, ensuring seniors can remain in the comfort and safety of their homes while receiving continuous support.

Families should consider 24-hour home care for their loved ones for several reasons. First, it provides unparalleled safety and security for seniors, especially those at risk of falls, wandering, or medical emergencies. Around-the-clock supervision ensures immediate response in critical situations, significantly reducing risks and providing peace of mind to family members.

Second, 24-hour care offers personalized attention and support, which can greatly improve a senior’s quality of life. Caregivers can assist with activities of daily living, medication management, meal preparation, and mobility, ensuring the senior’s physical and emotional needs are met consistently and with care.

Finally, 24-hour home care allows families to maintain balance and avoid caregiver burnout. Caring for a senior loved one can be physically and emotionally taxing. Professional care enables family members to focus on their personal well-being while ensuring their loved ones receive top-notch support from experienced professionals.

Families in Stamford seeking reliable home care solutions can benefit from:

Comprehensive 24-hour care services, including assistance with daily activities and medical needs.
A team of highly trained, compassionate caregivers dedicated to meeting individualized care plans.
Flexible care options designed to provide relief to family members and ensure seniors’ comfort.

For more information about Collaborative Home Care and their 24-hour care in Stamford, CT, please visit their website at https://collaborativehomecare.com

About Collaborative Home Care:

Collaborative Home Care is a premier provider of personalized home care services in Stamford, CT. Dedicated to delivering exceptional care, the company focuses on fostering independence, comfort, and well-being for seniors and their families. With a team of skilled caregivers and a compassionate approach, Collaborative Home Care remains a trusted partner in the community, offering support that truly makes a difference.

Media Contact
Company Name: Collaborative Home Care
Contact Person: Bryan Knust
Email: Send Email
Phone: +12035422808
Address:777 West Putnam Avenue
City: Greenwich
State: CT
Country: United States
Website: https://collaborativehomecare.com/

Cardinal Senior Care Empowers Families with Specialized Dementia Home Care in Alamo Heights

Providing peace of mind and expert care for loved ones with memory-related conditions.

Alamo Heights, TX – Cardinal Senior Care, a trusted provider of home care services, is reaffirming its dedication to serving families through its specialized dementia home care in Alamo Heights. This service offers compassionate, tailored solutions designed to improve the quality of life for individuals with dementia while assuring families that their loved ones are in expert hands.

“At Cardinal Senior Care, we understand the unique challenges families face when supporting a loved one with dementia,” said Hamid Mangalji, owner of Cardinal Senior Care. “Our Alamo Heights memory home care program is committed to delivering personalized care that prioritizes dignity, safety, and comfort. We’re proud to provide families with the support they need to navigate this journey confidently.”

The increasing demand for high-quality, in-home memory care underscores the importance of services that address the physical and emotional needs of individuals with dementia. Cardinal Senior Care’s dementia home care program focuses on creating a safe and nurturing environment, empowering families to maintain their loved one’s independence and well-being in the familiarity of their own homes.

Dementia affects not only memory but also behavior, mood, and physical health, often leading to challenges that require specialized support. Families may be overwhelmed by the constant care needs and the unpredictability of symptoms. Professional dementia home care provides a tailored approach that addresses these challenges, ensuring that individuals receive the attention they deserve without compromising their safety or quality of life.

Home care for dementia patients is critical because it allows individuals to remain in a familiar environment, which can help reduce confusion and anxiety. Familiar surroundings often play a critical role in stabilizing mood and enhancing security for those with memory-related conditions. Cardinal Senior Care emphasizes creating a routine and environment that promotes comfort and minimizes stress.

Moreover, families benefit from the peace of mind that comes with knowing their loved ones are in the hands of trained professionals. This support enables family members to focus on maintaining their emotional connection with their loved ones rather than being solely consumed by caregiving responsibilities. Cardinal Senior Care ensures that caregivers are skilled and compassionate, fostering trust and building strong relationships with clients and their families.

For more information about Cardinal Senior Care and their quality dementia home care in Alamo Heights, TX, please visit their website at https://cardinalseniorcare.com.

About Cardinal Senior Care:

Cardinal Senior Care is a leading home care provider specializing in personalized services for seniors and individuals with memory-related conditions. The company is dedicated to enhancing the lives of its clients through compassionate and professional care solutions. Their expert team is committed to helping families achieve peace of mind while ensuring their loved ones receive the highest standard of home care.

Media Contact
Company Name: Cardinal Senior Care
Contact Person: Hamid Mangalji
Email: Send Email
Phone: +1 210 316 4818
Address:4402 Vance Jackson Rd Suite# 202
City: San Antonio
State: TX
Country: United States
Website: https://cardinalseniorcare.com

Brazos Home Care Continues Commitment to Providing Long-Term Home Care for Disabled Veterans in Somerville, TX

Offering compassionate and personalized care to meet the unique needs of disabled veterans and their families

Somerville, TX – Brazos Home Care, a leading provider of in-home care services, reaffirms its dedication to supporting disabled veterans in the Somerville area. With a steadfast focus on enhancing the quality of life for those who have served the nation, the agency continues offering comprehensive long-term home care solutions designed to address veterans’ and their families’ physical and emotional needs. This initiative emphasizes the importance of enabling veterans to live with dignity and comfort in their own homes.

“At Brazos Home Care, we honor the sacrifices of our veterans by ensuring they receive the highest standard of care,” said Robert Palmarez, owner of Brazos Home Care. “Our mission is to create a supportive environment that promotes independence and well-being, allowing families to focus on cherishing time together. By offering personalized care plans, we aim to make a meaningful difference in the lives of the veterans and families we serve.”

The demand for reliable home care services tailored to the unique needs of disabled veterans has grown significantly in Somerville. Brazos Home Care addresses this need with a team of highly skilled caregivers trained in veteran-specific care protocols. Services include assistance with daily living activities, companionship, and specialized support for chronic conditions, ensuring veterans receive the compassionate care they deserve.

Long-term home care for disabled veterans provides a nurturing environment that promotes physical and emotional well-being. For many veterans, staying home amidst familiar surroundings can significantly improve their mental health by reducing stress and providing a sense of security. Additionally, home care fosters independence, allowing veterans to maintain control over their daily routines and activities with the support they need to thrive.

Families often struggle to balance caregiving responsibilities with work and personal commitments. Long-term home care solutions alleviate this burden by providing professional, reliable care tailored to veterans’ needs. This support allows families to focus on building meaningful relationships with their loved ones without the added stress of managing daily caregiving tasks.

Moreover, professional caregivers bring specialized expertise in handling complex medical conditions and mobility issues commonly faced by disabled veterans. These skilled professionals ensure that veterans receive the best possible care and help prevent hospital readmissions by closely monitoring health and proactively addressing issues. Long-term home care is a holistic approach that benefits veterans and their families by prioritizing health, dignity, and quality of life.

For more information about Brazos Home Care and their Long-Term Home Care for Disabled Veterans in Somerville, TX, please visit their website at https://brazoshomecare.com.

About Brazos Home Care:

Brazos Home Care is a premier provider of in-home care services in Somerville, TX, committed to improving the lives of individuals and families in the community. Specializing in care for disabled veterans, their dedicated team of professionals offers customized care solutions that prioritize respect, dignity, and independence. Brazos Home Care continues to be a trusted partner for families seeking exceptional home care services.

Media Contact
Company Name: Brazos Home Care
Contact Person: Robert Palmarez
Email: Send Email
Phone: +1 979 571 5750
Address:1135 N Earl Rudder Fwy suite 102
City: Bryan
State: TX 77803
Country: United States
Website: https://brazoshomecare.com

Discover the Power of Change and Self-Discovery in Noreen Doran’s New Book, Lil Rock’s Journey: A Metaphorical Tale of Living Through Change

Feb 6, 2025 – Noreen Doran, Ph.D., is proud to announce the release of her latest book, Lil Rock’s Journey: A Metaphorical Tale of Living Through Change, a compelling story that invites readers to explore the profound themes of change, resilience, and self-discovery through the eyes of an unlikely heroine—Lil Rock.

In this beautifully crafted metaphorical tale, readers are introduced to Lil Rock, a small yet resilient stone who unexpectedly finds herself swept away from her familiar surroundings into the vast, unpredictable currents of life. As she navigates the twists and turns of the river, Lil Rock learns to embrace the unknown, trust her inner voice, and discover the strength within herself to grow and evolve.

Lil Rock’s Journey is more than just a story; it is a universal metaphor for the challenges and opportunities that come with change. Whether readers are experiencing a personal transformation, facing unforeseen challenges, or simply seeking inspiration, Lil Rock’s adventure offers valuable insights and lessons on how to navigate life’s currents with grace and courage.

Key Themes and Features:

A Metaphor for Personal Growth: The river in Lil Rock’s journey symbolizes the flow of life, encouraging readers to trust the process, adapt to change, and find their own path forward.
Resilience and Inner Strength: Lil Rock’s story highlights the importance of resilience in the face of adversity and the power of listening to one’s inner voice, even when the journey is uncertain.
Self-Discovery: As Lil Rock journeys through the river, she uncovers deeper truths about herself and her place in the world, reflecting the universal human experience of self-discovery.
Beautifully Illustrated: The book features captivating illustrations that bring Lil Rock’s journey to life, making it a visual and emotional experience for readers of all ages.

About the Author

Noreen enjoyed a teaching career that included kindergarten through college. She received the prestigious “Teacher of the Handicapped Award” through Rotary International and received her Master’s degree in Education at the University of York, England. After starting a family, she began working on her PhD in Human Development. It was then that Lil Rock surfaced into her mind. She wrote a metaphorical tale of a rock that went on an unexpected adventure that showed her depth of understanding of Human Development theory. Needless to say, this story held a sweetness in her heart and has been revised heavily for today’s version. Currently, Noreen can be found mountain biking, hiking, kayaking, traveling, reading, or writing fiction.

Book Name: Lil Rock’s Journey

Author Name: Noreen Doran Ph.D

ISBN Number: 1917438893

Kindle Version: Click Here

Paperback Version: Click Here

Media Contact
Company Name: Books Publishing Company
Email: Send Email
Phone: +1-213-734-5718
Address:2425 West Loop South
City: Houston
State: Texas
Country: United States
Website: https://bookspublishingcompany.com

New Book Offers Groundbreaking Insights and Strategies for Managing ADHD

Feb 6, 2025 – Psychotherapist, Supervisor, ADHD Coach, and NLP Master Practitioner Nea Clark has released her highly anticipated new book, Travel into the ADHD: Mind Strategies for Working with ADHD Clients. This essential guide is designed to help therapists, counselors, and non-professionals alike gain a deeper understanding of ADHD, offering practical strategies to support neurodivergent individuals in managing their condition and thriving in their personal and professional lives.

In Travel into the ADHD, Clark combines years of clinical experience with the latest research on neurodiversity, delivering a comprehensive framework that blends psychology with real-world applications. The book is packed with actionable insights, including a 12-step treatment program that empowers professionals to work confidently with ADHD clients while also providing individuals with practical tools for managing their daily challenges.

“ADHD is one of the most misunderstood conditions in the mental health field,” says Clark. “Through this book, I aim to demystify the complexities of ADHD and provide both professionals and individuals with a clear, methodical approach to managing it. Whether you’re a therapist, a parent, or someone living with ADHD, there’s something here to help you navigate the challenges and live a more fulfilling life.”

About the Author

Nea Clark is a Psychotherapist, Supervisor, and ADHD Coach with several years of experience working with ADHD clients and supervisees. She is passionate about enabling practitioners to work confidently with ADHD individuals, helping them develop the skills needed to manage neurodivergence. Clark is also an advocate for neurodiversity, promoting awareness and understanding through her work and public speaking.

In Travel into the ADHD, Clark shares her personal and professional journey with ADHD, offering insights into how neurodiversity affects brain function, behavior, and emotional well-being. Her book is designed to help both professionals and individuals improve their lives by understanding and embracing neurodiversity.

Book Name: Travel into the ADHD Mind

Author Name: Nea Clark

ISBN Number: 1917438664

Kindle Version: Click Here

Paperback Version: Click Here

Media Contact
Company Name: Book Publishing Pros
Email: Send Email
Phone: +1-213-734-5715
Address:17595 Harvard Ave, Ste C-641
City: Irvine
State: California
Country: United States
Website: https://bookpublishingpros.co

Rising Staff: Connecting Talent with Real Opportunities in the U.S. Job Market

The Future of Workforce Efficiency in Logistics and Manufacturing

In today’s fast-paced economy, efficiency and reliability are the cornerstones of success for warehouses and production lines. The ability to build a strong, skilled workforce is not just an operational need—it’s a strategic advantage. Rising Staff is at the forefront of this transformation, providing innovative human resource solutions that empower businesses and workers alike.

The Workforce Driving the U.S. Supply Chain

Warehouses and production facilities are the backbone of the global supply chain, ensuring that goods reach their destinations on time. These industries require a dependable, highly motivated workforce that can adapt to evolving demands. Rising Staff bridges this gap by strategically sourcing and placing qualified talent where it’s needed most.

Unlike traditional staffing agencies, Rising Staff goes beyond simple placements. By understanding the unique challenges of logistics and manufacturing, we craft workforce solutions tailored to each company’s needs. Our approach reduces turnover, boosts productivity, and ensures that businesses remain competitive in an increasingly demanding market.

Why Rising Staff is the Go-To HR Partner for Warehouses and Production Lines

Hiring is no longer just about filling positions—it’s about optimizing performance. Rising Staff partners with businesses to provide seamless workforce solutions that align with long-term operational goals. Our expertise in logistics and production staffing ensures that companies can access the right talent at the right time.

From seasonal hiring surges to long-term workforce planning, we anticipate market trends and proactively address labor shortages. By leveraging data-driven insights and industry expertise, we streamline hiring processes, helping businesses reduce costs and increase efficiency.

A Smarter and More Strategic Approach to Workforce Management

At Rising Staff, we believe that people are the key to business success. Our recruitment strategies are designed to match the right talent with the right roles, creating a win-win situation for both employers and employees. We eliminate inefficiencies in the hiring process, allowing companies to focus on growth while ensuring workers have opportunities that support career advancement.

Rising Staff: Redefining Workforce Solutions for a Competitive Economy

As the demand for skilled, reliable workers in logistics and manufacturing continues to rise, Rising Staff remains a trusted leader in workforce solutions. We are not just filling positions—we are driving industry growth, ensuring that businesses thrive and workers find meaningful, rewarding careers.

For companies looking to strengthen their workforce and job seekers eager to advance their careers, Rising Staff is the strategic partner that delivers results. The future of workforce management is here, and we are leading the way.

Media Contact
Company Name: Rising Staff
Email: Send Email
Phone: 2394091633
Country: United States
Website: http://risingstaff.com/

Biocompatible Coatings Market, Size, Analytical Overview, CAGR, Growth Factors, Demand and Trends Forecast to 2028

“Browse 200 market data Tables and 70 Figures spread through 300 Pages and in-depth TOC on “Biocompatible Coatings Market””

The Biocompatible Coatings market is driven by rising demand in medical implants, pharmaceuticals, and biotechnology. Key players include Surmodics, Materion, DSM, and Covalon, focusing on innovation and advanced coating technologies. With ongoing R&D, the market is poised for steady growth, ensuring safer and more effective biomedical applications.

The report “Biocompatible Coatings Market by Type (Antibacterial, hydrophilic), Material (Polymer, Ceramics, Metal), End-Use Industry (Healthcare, Food & Beverage, Medical Devices), & Region (APAC, Europe, North America, MEA & SA) – Global Forecast to 2028”, size is estimated at USD 14.6 billion in 2022 to USD 29.7 billion by 2028, at a CAGR of 12.4%, between 2023 and 2028. The market research report provides access to critical information such as biocompatible coatings market growth drivers, market growth restraints, current market trends, the market’s economic and financial structure, and other key market details. The rapid growth of the healthcare industry, Rapid urbanization, population growth, and the increasing focus on hygiene and cleanliness drive the biocompatible coatings market. The biocompatible coatings market is divided into five key regions:Asia Pacific, Europe, North America, Europe, the Middle East & Africa, and South America. China and India, among other countries, are fastest growing biocompatible coatings market globally.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=32624649

The demand for biocompatible coatings is influenced by several factors. One crucial factor is the increasing focus on healthcare and medical advancements. With the continuous progress in medical technology and the growing emphasis on patient well-being, there is a higher demand for biocompatible coatings in various applications. These coatings play a vital role in enhancing the biocompatibility of medical devices, implants, and prosthetics, reducing the risk of adverse reactions and improving patient outcomes. The aging population and the prevalence of chronic diseases drive the demand for medical devices and implants, which, in turn, fuels the demand for biocompatible coatings. The companies have adopted various strategies, such as mergers & acquisitions, investment & expansion, joint ventures, & new product launches and to increase their global presence and maintain sustained growth in the biocompatible coatings market.

Polymer segment is expected to account for the largest share in 2022.

Polymers provide versatility, allowing for the development of coatings with tailored properties such as biocompatibility, durability, flexibility, and resistance to wear and corrosion. These characteristics make polymer coatings suitable for a diverse range of medical devices and implants, including orthopedic implants, cardiovascular stents, surgical instruments, and drug delivery systems. advancements in polymer technology have enabled the development of biodegradable coatings. These coatings gradually dissolve or degrade over time, reducing the need for additional surgical interventions to remove the coating. Bioresorbable polymer coatings are particularly advantageous for implantable devices, as they can facilitate tissue healing and integration. The widespread adoption of polymer-based biocompatible coatings can be attributed to their compatibility with various fabrication techniques, cost-effectiveness, and well-established manufacturing processes. These factors make polymer coatings more accessible and easier to integrate into existing medical device production workflows.

Get a Sample Copy of This Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=32624649

Food & Beverage segment is expected to account for the largest share in 2022.

The food and beverage segment is a crucial component of the biocompatible coatings industry, and it plays a vital role in ensuring the safety, quality, and shelf life of food and beverage products. Food and beverage packaging serves as a protective barrier that safeguards products from external factors such as moisture, light, air, and contaminants. It helps prevent spoilage, maintain product freshness, and extend shelf life. Advanced packaging materials and technologies, including biocompatible coatings, are employed to ensure optimal product protection and preservation. the food and beverage packaging segment is driven by the need for product protection, safety, branding, convenience, sustainability, and regulatory compliance. Biocompatible coatings play a significant role in enhancing the safety, functionality, and aesthetics of packaging materials in this segment, meeting the evolving demands of both consumers and regulatory bodies.

Asia Pacific is expected to register highest CAGR during the forecast period.

Asia Pacific region has a large and rapidly growing population, along with increasing healthcare expenditure. This demographic trend drives the demand for medical devices, implants, and related technologies, which in turn fuels the need for biocompatible coatings. The region’s rising middle class and improving healthcare infrastructure also contribute to the market growth.

There is a growing focus on medical tourism in countries like India, Thailand, and Malaysia, where patients from other countries seek medical treatments. This trend further drives the demand for advanced medical devices and implants, which often require biocompatible coatings. the region’s manufacturing capabilities and cost advantages attract global medical device manufacturers to establish production facilities in Asia Pacific countries. This factor supports the local production and consumption of biocompatible coatings, further contributing to market growth.

Biocompatible Coatings Market Companies

The major players in the global biocompatible coatings market are SurModics, Inc. (US), DSM Biomedical (US), Hydromer Inc. (US), Covalon Technologies Ltd. (Canada), and Hemoteq AG (Germany). These players opted for inorganic growth through mergers & acquisitions, agreements, and partnerships. For instance, in July 2021, SurModics, Inc. has acquired privately-held Vetex Medical Limited. The Galway, Ireland-based medical device developer and manufacturer has focused exclusively on venous clot removal solutions.

SurModics, Inc: SurModics, Inc. is a global provider of surface modification and in vitro diagnostic technologies. The company is headquartered in Eden Prairie, Minnesota, United States. SurModics has been operating for over four decades and has established itself as a leader in the field of biocompatible coatings and surface modification technologies. The company’s core focus is on developing and commercializing innovative solutions that enhance the performance, biocompatibility, and functionality of medical devices. SurModics offers a broad portfolio of biocompatible coatings designed to address various applications and industries, including cardiovascular, ophthalmology, neurology, and in-vitro diagnostics. SurModics’ biocompatible coatings provide functionalities such as lubricity, hydrophilicity, drug delivery, anti-thrombogenicity, and bioactive capabilities. These coatings are tailored to meet the specific requirements of medical devices, ensuring improved performance, reduced complications, and enhanced patient outcomes. SurModics collaborates with medical device manufacturers, pharmaceutical companies, and diagnostic testing laboratories to develop customized coating and surface modification solutions. The company’s team of scientists and engineers work closely with customers to understand their specific needs and deliver innovative solutions that address their challenges.

Inquire Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=32624649

In April 2020, Cook Medical and Surmodics, Inc. have announced a new distribution agreement in which Cook Medical will market two novel Surmodics products, hydrophilic percutaneous transluminal angioplasty (PTA) balloon catheters that may be utilised beyond 0.014-inch and 0.018-inch wire guides.

DSM Biomedical: DSM Biomedical is a division of DSM, a global science-based company headquartered in the Netherlands. DSM Biomedical specializes in developing and manufacturing biomedical materials and technologies, with a focus on providing innovative solutions for the medical device and healthcare industries. The company offers a wide range of products and solutions that address various medical applications, including orthopedics, cardiovascular devices, dental applications, drug delivery systems, and wound care. DSM Biomedical’s expertise lies in developing biocompatible materials, coatings, drug delivery systems, and regenerative solutions that enhance the performance, biocompatibility, and safety of medical devices. The company places a strong emphasis on sustainability and environmental responsibility. DSM Biomedical strives to develop materials and technologies that are eco-friendly and have minimal impact on the environment. This commitment aligns with the growing demand for sustainable solutions in the medical industry.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/biocompatible-coating-market-32624649.html

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Biocompatible Coatings Market, Size, Analytical Overview, CAGR, Growth Factors, Demand and Trends Forecast to 2028

Myelofibrosis Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies by DelveInsight

DelveInsight’s, “Myelofibrosis Pipeline Insight” report provides comprehensive insights about 35+ companies and 40+ pipeline drugs in Myelofibrosis pipeline landscape. It covers the Myelofibrosis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Myelofibrosis therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Stay ahead with the latest insights! Download DelveInsight’s comprehensive Myelofibrosis Pipeline Report to explore emerging therapies, key Myelofibrosis Companies, and future Myelofibrosis treatment landscapes @ Myelofibrosis Pipeline Outlook Report

Key Takeaways from the Myelofibrosis Pipeline Report

In January 2025:- Sumitomo Pharma America Inc.:- This study is a Phase 1/2, multicenter, dose-escalation, open-label trial to assess safety, tolerability, pharmacokinetics and pharmacodynamics of nuvisertib (TP-3654) in patients with intermediate or high-risk primary or secondary MF.
In January 2025:- Keros Therapeutics Inc.:- KER-050 is an investigational therapeutic protein designed to increase red blood cell and platelet production by inhibiting the signaling of a subset of the transforming growth factor beta (TGF-ß) family of proteins to promote hematopoiesis. It is being developed for the treatment of low blood cell counts, or cytopenias including anemia and thrombocytopenia in patients with Myelodysplastic Syndrome (MDS) and Myelofibrosis (MF)
In January 2025:- Geron Corporation:- The purpose of the study is to evaluate the overall survival of participants treated with imetelstat compared to best available therapy with intermediate-2 or high-risk Myelofibrosis (MF) who are relapsed/refractory (R/R) to Janus Kinase (JAK)-Inhibitor treatment.
In January 2025:- Karyopharm Therapeutics Inc.:- This is a global, multicenter, 2-part study to evaluate the efficacy and safety of selinexor plus ruxolitinib in JAK inhibitor (JAKi) treatment-naïve myelofibrosis (MF) participants. The study will be conducted in two phases: Phase 1 (open-label) and Phase 3 (double-blind). Phase 1 (enrollment completed) was an open-label evaluation of the safety and recommended Phase 2 dose (RP2D) of selinexor in combination with ruxolitinib and included a dose escalation using a standard 3+3 design (Phase 1a) and a dose expansion part (Phase 1b).
In January 2025:- Ryvu Therapeutics SA:- The objective of this clinical trial is to evaluate the efficacy (how well the drug works), safety, pharmacokinetics (PK), and pharmacodynamics (PD) of the study drug, RVU120, in treating adult patients with intermediate or high-risk, primary or secondary myelofibrosis. RVU120 will be given as a single agent or in combination with ruxolitinib.
DelveInsight’s Myelofibrosis pipeline report depicts a robust space with 35+ active players working to develop 40+ pipeline therapies for Myelofibrosis treatment.
The leading Myelofibrosis Companies such as Geron Corporation, Merck, Telios Pharma Inc., Ryvu Therapeutics SA, Taiga Biotechnologies, Inc., Morphic Therapeutic, iOnctura, Pharmaxis, Nippon Shinyaku, Active Biotech, Incyte Corporation, Sumitomo Pharma America, Inc., and others.
Promising Myelofibrosis Therapies such as Momelotinib, Luspatercept, Bomedemstat, Pacritinib, RVU120, Ruxolitinib, and others.

Discover how the Myelofibrosis treatment paradigm is evolving. Access DelveInsight’s in-depth Myelofibrosis Pipeline Analysis for a closer look at promising breakthroughs @ Myelofibrosis Clinical Trials and Studies

Myelofibrosis Emerging Drugs Profile

Imetelstat: Geron Corporation

Imetelstat sodium (imetelstat) is a small oligonucleotide composed of a nucleic acid and a lipid moiety. The proprietary nucleic acid backbone provides resistance to degradation, thus conferring improved stability in plasma and tissues, as well as significantly improved binding affinity to its target. The lipid group enhances cell permeability, which results in increased potency and improved pharmacokinetic and pharmacodynamic properties.

Bomedemstat: Merck

Bomedemstat is an irreversible inhibitor of lysine-specific demethylase 1 (LSD1), an enzyme critical for regulating the proliferation of hematopoietic stem cells and the maturation of progenitors. Currently, the drug is in Phase III stage of its clinical trial for the treatment of Myelofibrosis.

TL-895: Telios Pharma, Inc.

It is an orally bioavailable inhibitor of tyrosine kinase, with potential anti-inflammatory and antineoplastic activities. Upon oral administration, tyrosine kinase inhibitor TL-895 targets, binds to, and inhibits tyrosine kinase. This may result in the inhibition of tumor angiogenesis and cell proliferation, and the inhibition of immune-mediated inflammatory processes. Currently, the drug is in Phase II stage of its clinical trial for the treatment of Myelofibrosis.

RVU120: Ryvu Therapeutics SA

RVU120 is a selective, first-in-class dual CDK8/19 kinase inhibitor developed by Ryvu Therapeutics. RVU120’s mechanism of action (MoA) involves targeting CDK8/19 kinases. Specifically, translational data confirm the proposed MoA in a molecularly-defined subset of patients with DNMT3A and NPM1 mutations. Currently, the drug is in the Phase II stage of development to treat Myelofibrosis.

TBX-2400: Taiga Biotechnologies, Inc.

TBX-2400 is an allogeneic stem cell therapy developed by Taiga Biotechnologies that aims to improve the rate of engraftment and reconstitution of the immune system for patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT). Currently, the drug is in the Phase I stage of development to treat Myelofibrosis.

Get a detailed analysis of the latest innovations in the Myelofibrosis pipeline. Explore DelveInsight’s expert-driven report today! @ Myelofibrosis Unmet Needs

Myelofibrosis Companies

Geron Corporation, Merck, Telios Pharma Inc., Ryvu Therapeutics SA, Taiga Biotechnologies, Inc., Morphic Therapeutic, iOnctura, Pharmaxis, Nippon Shinyaku, Active Biotech, Incyte Corporation, Sumitomo Pharma America, Inc., and others.

Myelofibrosis pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as

Oral
Intravenous
Subcutaneous
Parenteral
Topical

Myelofibrosis Products have been categorized under various Molecule types such as

Recombinant fusion proteins
Small molecule
Monoclonal antibody
Peptide
Polymer
Gene therapy

Download DelveInsight’s latest report to gain strategic insights into upcoming Myelofibrosis Therapies and key Myelofibrosis Developments @ Myelofibrosis Market Drivers and Barriers, and Future Perspectives

Scope of the Myelofibrosis Pipeline Report

Coverage- Global
Myelofibrosis Companies- Geron Corporation, Merck, Telios Pharma Inc., Ryvu Therapeutics SA, Taiga Biotechnologies, Inc., Morphic Therapeutic, iOnctura, Pharmaxis, Nippon Shinyaku, Active Biotech, Incyte Corporation, Sumitomo Pharma America, Inc., and others.
Myelofibrosis Therapies- Momelotinib, Luspatercept, Bomedemstat, Pacritinib, RVU120, Ruxolitinib, and others.
Myelofibrosis Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
Myelofibrosis Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III

Which companies are leading the race in Myelofibrosis drug development? Find out in DelveInsight’s exclusive Myelofibrosis Pipeline Report—access it now! @ Myelofibrosis Emerging Drugs and Major Companies

Table of Content

Introduction
Executive Summary
Myelofibrosis: Overview
Myelofibrosis Pipeline Therapeutics
Myelofibrosis Therapeutic Assessment
Myelofibrosis – DelveInsight’s Analytical Perspective
Late Stage Products (Phase III)
Imetelstat: Geron Corporation
Drug profiles in the detailed report…..
Mid Stage Products (Phase II)
RVU120: Ryvu Therapeutics SA
Drug profiles in the detailed report…..
TBX-2400: Taiga Biotechnologies, Inc.
Drug profiles in the detailed report…..
Preclinical and Discovery Stage Products
Drug name: Company name
Drug profiles in the detailed report…..
Inactive Products
Myelofibrosis Key Companies
Myelofibrosis Key Products
Myelofibrosis- Unmet Needs
Myelofibrosis- Market Drivers and Barriers
Myelofibrosis- Future Perspectives and Conclusion
Myelofibrosis Analyst Views
Appendix

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 9650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/report-store/antibody-drug-conjugate-market

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Myelofibrosis Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies by DelveInsight